Influence of Endosome-Destabilizing Peptides on Efficacy of Anti-HIV Immunotoxins
- 1 January 1997
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 8 (1), 38-43
- https://doi.org/10.1021/bc9600729
Abstract
The effects on immunotoxin efficacy of fusogenic peptides derived from influenza virus hemagglutinin have been studied. These peptides have an amphipathic nature and change conformation from random at pH 7 to helical at pH 5. Fusogenic peptides are reported to destabilize endosomal membranes, resulting in the release of contents into the cytoplasm. The use of two related fusogenic peptides to enhance the efficacy of anti-HIV immunotoxins is described. The direct toxicity of the peptides was tested on HIV-infected H9/NL4-3 cells. Peptide HA24 was considerably more toxic than HA23. The peptides were mixed with two different immunotoxins. Immunotoxin action was enhanced by both peptides, with HA24 providing greater enhancement than HA23. Immunotoxins were then constructed by coupling HA23 or HA24 to the targeting antibody with disulfide-containing linkers. Peptide HA23 enhanced the activity of the immunotoxin 4−5-fold. Surprisingly, HA24 significantly inhibited immunotoxin activity. Coupling the peptides to the immunotoxin had no effect on antigen binding characteristics or the activity of the toxic moiety. Bafilomycin A1, an agent that inhibits vacuolar acidification, markedly potentiated the effects of all immunotoxins. These results demonstrate that amphipathic peptides can influence the efficacy of immunotoxins, but in sometimes unpredictable ways.Keywords
This publication has 11 references indexed in Scilit:
- Self-potentiation of Ligand-Toxin Conjugates Containing Ricin A Chain Fused with Viral StructuresJournal of Biological Chemistry, 1995
- The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems.Journal of Biological Chemistry, 1994
- Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees.Journal of Clinical Investigation, 1993
- Monoclonal antibodies in cancer detection and therapyAmerican Journal Of Medicine, 1993
- AZT Demonstrates Anti-HIV-l Activity in Persistently Infected Cell Lines: Implications for Combination Chemotherapy and ImmunotherapyThe Journal of Infectious Diseases, 1990
- CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses.Proceedings of the National Academy of Sciences, 1989
- Treatment of HIV tissue culture infection with monoclonal antibody-ricin A chain conjugates.The Journal of Immunology, 1989
- Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular cloneJournal of Virology, 1986
- The effect of antibody valency and lysosomotropic amines on the synergy between ricin A chain- and ricin B chain-containing immunotoxins.The Journal of Immunology, 1986
- Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagentBiochemical Journal, 1978